Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TLR4 | O00206 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10603303 | 0.83 | NPC1 (0.48) | KDM4EALDH1A1KMT2AHPGDLMNA | |
| SCHEMBL10832062 | 0.83 | CRBN (0.43) | RAB9AMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL9546789 | 0.80 | GAA (0.38) | RAB9AMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL6619679 | 0.80 | RAB9A (0.37) | RAB9AMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL11022447 | 0.79 | TSHR (0.39) | KDM4EALDH1A1KMT2AGAAHTT | |
| SCHEMBL27296485 | 0.79 | MAP3K14 (0.33) | RAB9AMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL6328278 | 0.78 | ALDH1A1 (0.36) | MAPTKDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL29967266 | 0.76 | MAPK1 (0.42) | ALDH1A1MEN1KMT2AGAAADORA2B | |
| SCHEMBL14809551 | 0.76 | MAPT (0.43) | RAB9AMAPTKDM4EALDH1A1MEN1 | |
| SCHEMBL10361090 | 0.76 | KDM4E (0.53) | RAB9AMAPTKDM4EALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415487-B2 | Process for preparing (3R)-2′-(4-bromo-2-fluorobenzyl)spiro-[pyrrolidine-3,4′(1′H)-pyrrolo[1,2-A]pyrazine]-1′,2,3′,5(2H′)-tetraone | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8389742-B2 | 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8389742-B2 | 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8389742-B2 | 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20120010405-A1 | OPTICALLY ACTIVE 3-AMINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE COMPOUND, AND USE OF THE COMPOUND | TANAKA DAISUKE (JP) | 2012-01-12 | — | — | US | disclosed |
| US-8058456-B2 | Optically active 3-amino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the compound, and use of the compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-11-15 | — | — | US | disclosed |
| US-8003808-B2 | 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates, process for production of the same, and use of the same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-8003808-B2 | 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylates, process for production of the same, and use of the same | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-08-23 | — | — | US | disclosed |
| US-20110201807-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | TANAKA DAISUKE | 2011-08-18 | — | — | US | disclosed |
| US-20110201807-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | TANAKA DAISUKE | 2011-08-18 | — | — | US | disclosed |
| US-20090286980-A1 | OPTICALLY ACTIVE 3-AMINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE COMPOUND, AND USE OF THE COMPOUND | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090253917-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATES, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090253917-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATES, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-10-08 | — | — | US | disclosed |
| EP-0148777-B1 | PHOSPHOLIPIDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1988-07-27 | — | — | EP | disclosed |
| US-4650791-A | ASTHMA | Takedo Chemical Industries, Ltd. (JP) | 1987-03-17 | — | — | US | disclosed |
| US-4578378-A | (Oxoheterocyclic carbonamido)cephem carboxylic acid derivatives | SHIONOGI & CO., LTD. (JP) | 1986-03-25 | — | — | US | disclosed |
| EP-0148777-A2 | Phospholipids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1985-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253917-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATES, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | SLC5A1, TERT, CBR3 | RAB9A 1161/4885MAPT 494/4885KDM4E 1902/4885 |
| US-20090286980-A1 | OPTICALLY ACTIVE 3-AMINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE COMPOUND, AND USE OF THE COMPOUND | REN, GPR119, RANBP1 | RAB9A 266/4885MAPT 251/4885KDM4E 2004/4885 |
| US-20120010405-A1 | OPTICALLY ACTIVE 3-AMINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE COMPOUND, AND USE OF THE COMPOUND | REN, GPR119, RANBP1 | RAB9A 266/4885MAPT 251/4885KDM4E 2004/4885 |
| US-20110201807-A1 | 3-HYDRAZINO-2,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, PROCESS FOR PRODUCTION OF THE SAME, AND USE OF THE SAME | CBR3, TERT, NOX4 | RAB9A 866/4885MAPT 429/4885KDM4E 1858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.